Foot-and-mouth disease vaccines: recent updates and future perspectives

被引:48
|
作者
Kamel, Mohamed [1 ]
El-Sayed, Amr [1 ]
Castaneda Vazquez, Hugo [2 ]
机构
[1] Cairo Univ, Fac Vet Med, Dept Med & Infect Dis, Giza, Egypt
[2] Univ Guadalajara, Div Vet Sci, Lab Mastitis & Mol Diagnost, Guadalajara, Jalisco, Mexico
关键词
EXPRESSING CAPSID PROTEINS; PRECURSOR POLYPEPTIDE P1; T-CELL EPITOPES; DNA VACCINE; IMMUNE-RESPONSES; VP1; PROTEIN; VIRUS FMDV; PSEUDORABIES VIRUS; PARTIAL PROTECTION; ANTIBODY-RESPONSE;
D O I
10.1007/s00705-019-04216-x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Foot-and-mouth disease (FMD) is a major worldwide viral disease in animals, affecting the national and international trade of livestock and animal products and leading to high economic losses and social consequences. Effective control measures of FMD involve prevention through vaccination with inactivated vaccines. These inactivated vaccines, unfortunately, require short-term protection and cold-chain and high-containment facilities. Major advances and pursuit of hot topics in vaccinology and vectorology are ongoing, involving peptide vaccines, DNA vaccines, live vector vaccines, and novel attenuated vaccines. DIVA capability and marker vaccines are very important in differentiating infected animals from vaccinated animals. This review focuses on updating the research progress of these novel vaccines, summarizing their merits and including ideas for improvement. HighlightsShortcomings of current vaccination strategiesPromising novel vaccines for FMD eradicationReverse genetics and new molecular technologies leading to vaccine improvementMarker vaccines and FMD control policyImmunoregulatory gene addition and FMD vaccine immunogenicity
引用
收藏
页码:1501 / 1513
页数:13
相关论文
共 50 条
  • [21] FUTURE PLANNING FOR FOOT-AND-MOUTH DISEASE CONTROL
    BEYNON, AG
    VETERINARY RECORD, 1970, 87 (07) : 209 - &
  • [22] Foot-and-mouth disease: past, present and future
    Syed M Jamal
    Graham J Belsham
    Veterinary Research, 44
  • [23] USE OF ACETYLETHYLENEIMINE IN PRODUCTION OF INACTIVATED FOOT-AND-MOUTH DISEASE VACCINES
    BROWN, F
    STHYSLOP, NG
    CRICK, J
    MORROW, AW
    JOURNAL OF HYGIENE, 1963, 61 (03): : 337 - +
  • [24] Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory
    Paton, D. J.
    Reeve, R.
    Capozzo, A. V.
    Ludi, A.
    VACCINE, 2019, 37 (37) : 5515 - 5524
  • [25] Research on improved foot-and-mouth disease vaccines facing challenges
    Stencel, C
    ASM NEWS, 2001, 67 (06): : 290 - 292
  • [26] DERIVATIVES OF AZIRIDINE AS INACTIVANTS FOR FOOT-AND-MOUTH DISEASE VIRUS VACCINES
    WARRINGTON, RE
    CUNLIFFE, HR
    BACHRACH, HL
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1973, 34 (08) : 1087 - 1091
  • [27] Requirements for improved vaccines against foot-and-mouth disease epidemics
    Park, Jong-Hyeon
    CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2013, 2 (01) : 8 - 18
  • [28] Mouse model as an efficacy test for foot-and-mouth disease vaccines
    Gnazzo, Victoria
    Quattrocchi, Valeria
    Soria, Ivana
    Pereyra, Erica
    Langellotti, Cecilia
    Pedemonte, Andrea
    Lopez, Virginia
    Marangunich, Laura
    Zamorano, Patricia
    TRANSBOUNDARY AND EMERGING DISEASES, 2020, 67 (06) : 2507 - 2520
  • [29] Vaccines against foot-and-mouth disease - the current state of knowledge
    Szweda, W
    Siwicki, AK
    MEDYCYNA WETERYNARYJNA-VETERINARY MEDICINE-SCIENCE AND PRACTICE, 2002, 58 (09): : 661 - 665
  • [30] Progress in the development of DNA vaccines against foot-and-mouth disease
    Fowler, Veronica L.
    Barnett, Paul V.
    EXPERT REVIEW OF VACCINES, 2012, 11 (04) : 481 - 493